skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Richard


+27 year(s) experience

As our Head of Medtech, Richard Faint delivers client solutions using financial forecasting, clinical data, epidemiology and primary market research. His expertise includes oncology, hematology, cardiovascular, infectious diseases and immunology, among many other areas.

Richard has extensive clinical and commercial experience gained from hospital practice, pharma and medtech research and consultancy.

Before joining us in 2003, Richard worked for over 10 years for a biophamaceutical company specializing in the discovery and development of novel drugs. Richard has experience in developmental diagnostics, in cancer therapeutics, as well as immunology and cardiovascular diseases. With an MBA (OUBS) and a PhD in cell signaling mechanisms (UCL), Richard is excited by the advances that deliver deeper understanding of life-threatening diseases, and new treatment opportunities.